Literature DB >> 21234065

[Not Available].

C Grondin.   

Abstract

Rheumatoid arthritis is the most common chronic inflammatory joint disease. To overcome joint inflammation and eventually induce disease remission, the physician must often use drugs that are more and more toxic. Indications, method of administration, and common adverse effects of non-steroidal anti-inflammatory drugs, local steroid injections, second-line agents, and steroids are reviewed. The author briefly discusses a new therapeutic concept and emphasizes the importance of patient education and early referral to an interdisciplinary rehabilitation team.

Entities:  

Year:  1990        PMID: 21234065      PMCID: PMC2280671     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  32 in total

Review 1.  The mechanisms of action of nonsteroidal antiinflammatory drugs.

Authors:  S B Abramson; G Weissmann
Journal:  Arthritis Rheum       Date:  1989-01

2.  Congestive heart failure due to nonsteroidal anti-inflammatory drugs in the elderly.

Authors:  F A Van den Ouweland; F W Gribnau; R H Meyboom
Journal:  Age Ageing       Date:  1988-01       Impact factor: 10.668

3.  Patient communication and effective rheumatology.

Authors:  D E Caughey
Journal:  J Rheumatol       Date:  1989-01       Impact factor: 4.666

Review 4.  Antirheumatic drug treatment during pregnancy and lactation.

Authors:  M Ostensen; G Husby
Journal:  Scand J Rheumatol       Date:  1985       Impact factor: 3.641

Review 5.  Non-steroidal and analgesic therapy in the elderly.

Authors:  S I Schlegel; H E Paulus
Journal:  Clin Rheum Dis       Date:  1986-04

6.  Long-term outcome of treating rheumatoid arthritis: results after 20 years.

Authors:  D L Scott; D P Symmons; B L Coulton; A J Popert
Journal:  Lancet       Date:  1987-05-16       Impact factor: 79.321

7.  Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin.

Authors:  G Ciabattoni; G A Cinotti; A Pierucci; B M Simonetti; M Manzi; F Pugliese; P Barsotti; G Pecci; F Taggi; C Patrono
Journal:  N Engl J Med       Date:  1984-02-02       Impact factor: 91.245

8.  Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.

Authors:  H J Moens; B J Ament; B W Feltkamp; J K van der Korst
Journal:  J Rheumatol       Date:  1987-12       Impact factor: 4.666

Review 9.  Rheumatoid arthritis and pregnancy.

Authors:  G L Klipple; F A Cecere
Journal:  Rheum Dis Clin North Am       Date:  1989-05       Impact factor: 2.670

10.  Anti-inflammatory therapy during pregnancy and lactation.

Authors:  P Lee
Journal:  Clin Invest Med       Date:  1985       Impact factor: 0.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.